Table 1. Characteristics of the study population broken down by TB and HIV status.
NA indicates that information for the specified characteristic was not available for a study subject. CD4 cell counts were only available for TB/HIV+ subjects. Alere LF-LAM results were only available for subjects with urine samples. Matched urine and serum samples were available for 69 of the 81 subjects. The remaining 12 subjects consisted of 6 TB+/HIV- subjects with only urine samples and 6 TB+/HIV- subjects with only serum samples.
| All Subjects | TB Negative | TB Positive | |||
|---|---|---|---|---|---|
| HIV Negative | HIV Positive | HIV Negative | HIV Positive | ||
| Category | No. of Subjects (% of Total) | ||||
| All subjects | 81 (100%) | 20 (25%) | 21 (26%) | 15 (19%) | 25 (31%) |
| Gender | |||||
| Female | 23 (28%) | 6 (7%) | 5 (6%) | 5 (6%) | 7 (9%) |
| Male | 53 (65%) | 9 (11%) | 16 (20%) | 10 (12%) | 18 (22%) |
| NA | 5 (6%) | 5 (6%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Age | |||||
| 18 to 40 | 51 (63%) | 6 (8%) | 14 (17%) | 12 (15%) | 19 (23%) |
| 41 to 60 | 25 (31%) | 13 (16%) | 6 (7%) | 2 (2%) | 4 (5%) |
| 61+ | 2 (2%) | 1 (1%) | 0 (0%) | 1 (1%) | 0 (0%) |
| NA | 3 (4%) | 0 (0%) | 1 (1%) | 0 (0%) | 2 (2%) |
| Location | |||||
| Bangladesh | 5 (6%) | 5 (6%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Peru | 19 (23%) | 3 (4%) | 14 (17%) | 2 (2%) | 0 (0%) |
| South Africa | 20 (25%) | 2 (3%) | 5 (6%) | 5 (6%) | 8 (10%) |
| Vietnam | 37 (46%) | 10 (12%) | 2 (2%) | 8 (10%) | 17 (21%) |
| CD4 Count | |||||
| <= 100 cells/μL | 14 (17%) | 0 (0%) | 0 (0%) | 0 (0%) | 14 (17%) |
| > 100 cells/μL | 8 (10%) | 0 (0%) | 0 (0%) | 0 (0%) | 8 (10%) |
| NA | 59 (73%) | 20 (25%) | 21 (26%) | 15 (19%) | 3 (4%) |
| Alere | |||||
| Negative | 62 (77%) | 20 (25%) | 15 (19%) | 13 (16%) | 14 (17%) |
| Positive | 13 (16%) | 0 (0%) | 0 (0%) | 2 (2%) | 11 (14%) |
| NA | 6 (7%) | 0 (0%) | 6 (7%) | 0 (0%) | 0 (0%) |
| Serum and Urine | |||||
| Matched | 69 (85%) | 20 (25%) | 9 (11%) | 15 (19%) | 25 (31%) |